German startup Pacifico Biolabs closed a €7M Series A round to scale production and launch its mycelium-based chicken alternative across European markets by late 2026. The company grows fungal protein in repurposed beer-brewing fermentation tanks, a method it claims saves more than 95% of the capital expenditure required by conventional biomass fermentation approaches. The model directly targets the three persistent obstacles in alternative protein: cost, texture, and nutriti